Acquisition - June 7, 2013
Enzymatica signs agreement with Actavis
Enzymatica and the international pharmaceuticals company, Actavis, have signed a letter of intent on the sale of Enzymatica’s cold treatment product, ColdZyme Mouth Spray, on the Nordic market. Under the agreement, the product will be on sale in around 3,200 pharmacies and a large number of stores, including health food retailers, in the Nordic region. Actavis […]
Acquisition - June 7, 2013
Allenex sells Anamar
Investment company Allenex has agreed to sell its holding in Anamar AB to the company’s main owner Koncentra Holding. Allenex became an owner in AnaMar 1998, whose focus area is chronic joint diseases. However, Allenex has not participated in the financing of AnaMar in recent years and the equity that now is being sold equal about 2,1 […]
Acquisition - May 29, 2013
AstraZeneca acquires Omthera Pharmaceuticals
AstraZeneca has entered into a definitive agreement to acquire Omthera Pharmaeuticals for up to $443m. The specialty pharmaceutical company is based in Princeton, New Jersey, and focuses on the development and commercialization of new therapies for abnormal levels of lipids in the blood, referred to as dyslipidemia. The company’s investigational product, EpanovaTM, is aimed at […]
CRO - May 24, 2013
CROs in collaboration
Nordic Life Science Review has talked to Peter Asplund at ASCRO who gave us some insight into the last months’ activities and current issues among CROs.
Acquisition - May 24, 2013
Novo A/S acquires Xellia Pharmaceuticals
Novo A/S, the holding company of the Novo Group, has purchased all shares in pharmaceutical group Xellia Pharmaceuticals for approximately USD 700 million. Xellia will now revert to Danish ownership with headquarters in Copenhagen, Denmark following the recent acquisition. Xellia Pharmaceuticals focuses on development, manufacturing and global commercialization of anti-infective therapies. Since its spin-out from Alpharma […]
Biotech Award - May 22, 2013
Affibody wins SwedenBIO Award
Swedish biotech company Affibody received this year’s SwedenBIO Award during SwedenBIO’s annual conference on May 21 in Stockholm. The jury’s motivation was that “Affibody has on a long-term basis established a well-functioning and successful business model. Affibody has unique technology platform as the basis of the development of protein drugs and imaging products, adapted for […]
